Form 4 holding
10%+ Owner
Protalix BioTherapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 3,637,314
- Estimated value
- $5,128,613
- Report date
- 03 Jun 2021
- Price
- $1.41
- Ownership
- Direct
Dexcel Pharma Technologies Ltd. - 10%+ Owner at Protalix BioTherapeutics, Inc.
Insider Transactions and Holdings
- Entity Type
- Company
- Role
- 10%+ Owner
- Issuer Symbol
- PLX on NYSE
- All Insider Reports
- All Insider Reports
There are no Buy or Sell transactions made by Dexcel Pharma Technologies Ltd. since 26 May 2025
Holdings reported by Dexcel Pharma Technologies Ltd. for Protalix BioTherapeutics, Inc.
Transactions reported by Dexcel Pharma Technologies Ltd. for Protalix BioTherapeutics, Inc.
| Sym | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.